Treatment with MV significantly reduced the releases of proinflammatory factors TNF-α, IL-1β, and increased the levels of anti-inflammatory factors IL-2 in mice with colitis, indicating its good anti-inflammatory effects. The gene discussed is TNF; the disease is colitis.